Trastuzumab treatment in patients with breast cancer and metastatic

Trastuzumab emtansine is a HER2-targeted, microtubule-stabilizing antibody-drug conjugate with about 3 chemotherapy molecules per antibody

Trastuzumab exerts an antitumour activity and is used in the treatment of HER2-positive breast cancer HER2 protein overexpression is observed in 20%-30% of

trastuzumab Trastuzumab deruxtecan is a HER2 directed antibody-drug conjugate The humanized IgG1 monoclonal antibody is linked to

trastuzumab Trastuzumab deruxtecan may cause hair loss Any hair loss caused should be temporary and in most cases your hair will begin to grow back once your treatment has